Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes.

Amigó N, Mallol R, Heras M, Martínez-Hervás S, Blanco Vaca F, Escolà-Gil JC, Plana N, Yanes Ó, Masana L, Correig X.

Sci Rep. 2016 Jan 18;6:19249. doi: 10.1038/srep19249.

2.

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Hafiane A, Genest J.

BBA Clin. 2015 Jan 31;3:175-88. doi: 10.1016/j.bbacli.2015.01.005. Review.

3.

Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet.

Nam M, Choi MS, Jung S, Jung Y, Choi JY, Ryu do H, Hwang GS.

Sci Rep. 2015 Nov 23;5:16984. doi: 10.1038/srep16984.

4.

Metabolomics and partial least square discriminant analysis to predict history of myocardial infarction of self-claimed healthy subjects: validity and feasibility for clinical practice.

Mohamad N, Ismet RI, Rofiee M, Bannur Z, Hennessy T, Selvaraj M, Ahmad A, Nor F, Abdul Rahman T, Md Isa K, Ismail A, Teh LK, Salleh MZ.

J Clin Bioinforma. 2015 Mar 13;5:3. doi: 10.1186/s13336-015-0018-4.

5.

Atomistic MD simulation reveals the mechanism by which CETP penetrates into HDL enabling lipid transfer from HDL to CETP.

Cilpa-Karhu G, Jauhiainen M, Riekkola ML.

J Lipid Res. 2015 Jan;56(1):98-108. doi: 10.1194/jlr.M054288.

6.

Impact of estimated HDL particle size via the ratio of HDL-C and apoprotein A-I on short-term prognosis of diabetic patients with stable coronary artery disease.

Hong LF, Yang B, Luo SH, Li JJ.

J Geriatr Cardiol. 2014 Sep;11(3):245-52. doi: 10.11909/j.issn.1671-5411.2014.03.015.

7.

Lipid concentrations and couple fecundity: the LIFE study.

Schisterman EF, Mumford SL, Browne RW, Barr DB, Chen Z, Louis GM.

J Clin Endocrinol Metab. 2014 Aug;99(8):2786-94. doi: 10.1210/jc.2013-3936.

8.

HDL in CKD: how good is the "good cholesterol?".

de Boer IH, Brunzell JD.

J Am Soc Nephrol. 2014 May;25(5):871-4. doi: 10.1681/ASN.2014010062. No abstract available.

9.

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids.

Orešič M, Hyötyläinen T, Kotronen A, Gopalacharyulu P, Nygren H, Arola J, Castillo S, Mattila I, Hakkarainen A, Borra RJ, Honka MJ, Verrijken A, Francque S, Iozzo P, Leivonen M, Jaser N, Juuti A, Sørensen TI, Nuutila P, Van Gaal L, Yki-Järvinen H.

Diabetologia. 2013 Oct;56(10):2266-74. doi: 10.1007/s00125-013-2981-2.

10.

Metabolomics in the studies of islet autoimmunity and type 1 diabetes.

Oresic M.

Rev Diabet Stud. 2012 Winter;9(4):236-47. doi: 10.1900/RDS.2012.9.236. Review.

11.

Interfacial properties of high-density lipoprotein-like lipid droplets with different lipid and apolipoprotein A-I compositions.

Koivuniemi A, Sysi-Aho M, Orešič M, Ollila S.

Biophys J. 2013 May 21;104(10):2193-201. doi: 10.1016/j.bpj.2013.02.058.

12.

Sphingomyelin in high-density lipoproteins: structural role and biological function.

Martínez-Beamonte R, Lou-Bonafonte JM, Martínez-Gracia MV, Osada J.

Int J Mol Sci. 2013 Apr 9;14(4):7716-41. doi: 10.3390/ijms14047716. Review.

13.

Unraveling the complexities of the HDL lipidome.

Kontush A, Lhomme M, Chapman MJ.

J Lipid Res. 2013 Nov;54(11):2950-63. doi: 10.1194/jlr.R036095. Review.

14.

A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake.

Szymańska E, van Dorsten FA, Troost J, Paliukhovich I, van Velzen EJ, Hendriks MM, Trautwein EA, van Duynhoven JP, Vreeken RJ, Smilde AK.

Metabolomics. 2012 Oct;8(5):894-906.

15.

Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects.

Ottestad I, Hassani S, Borge GI, Kohler A, Vogt G, Hyötyläinen T, Orešič M, Brønner KW, Holven KB, Ulven SM, Myhrstad MC.

PLoS One. 2012;7(8):e42550. doi: 10.1371/journal.pone.0042550.

16.

Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia.

Orešič M, Seppänen-Laakso T, Sun D, Tang J, Therman S, Viehman R, Mustonen U, van Erp TG, Hyötyläinen T, Thompson P, Toga AW, Huttunen MO, Suvisaari J, Kaprio J, Lönnqvist J, Cannon TD.

Genome Med. 2012 Jan 18;4(1):1. doi: 10.1186/gm300.

17.

Whole grain products, fish and bilberries alter glucose and lipid metabolism in a randomized, controlled trial: the Sysdimet study.

Lankinen M, Schwab U, Kolehmainen M, Paananen J, Poutanen K, Mykkänen H, Seppänen-Laakso T, Gylling H, Uusitupa M, Orešič M.

PLoS One. 2011;6(8):e22646. doi: 10.1371/journal.pone.0022646.

18.

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy.

Yetukuri L, Huopaniemi I, Koivuniemi A, Maranghi M, Hiukka A, Nygren H, Kaski S, Taskinen MR, Vattulainen I, Jauhiainen M, Orešič M.

PLoS One. 2011;6(8):e23589. doi: 10.1371/journal.pone.0023589.

19.

Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses.

Han X, Yang K, Gross RW.

Mass Spectrom Rev. 2012 Jan-Feb;31(1):134-78. doi: 10.1002/mas.20342. Review.

20.

Lipid simulations: a perspective on lipids in action.

Vattulainen I, Rog T.

Cold Spring Harb Perspect Biol. 2011 Apr 1;3(4). pii: a004655. doi: 10.1101/cshperspect.a004655. Review.

Supplemental Content

Support Center